Subset of Patients With Richter Syndrome May Obtain Long-Term Survival
Data from Spain add to the knowledge of Richter syndrome.
Hematologic Cancer
HEMATOLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
A Missed Opportunity in Expanded Access Limits Real-World Insights
An expanded access protocol for gemtuzumab ozogamicin gathered only safety data, no efficacy data, limiting insights into real-world use. -
Treating Strategies for Patients With Relapsed/Refractory Acute Myeloid Leukemia
Although numerous clinical studies have aimed to treat AML, most results have been disappointing, according to authors of a publication in Blood. -
Could Checkpoint Blockade Be Useful in Non-Hodgkin Lymphoma After All?
A study suggested that the immunotherapy could be sensitizing non-Hodgkin lymphoma patients to subsequent therapies. -
Direct-to-Drug Screening Tool Allows for Precision Medicine in Multiple Myeloma
An assay from Mayo Clinic researchers screens multiple myeloma drugs to see how cells with different biomarkers and pretreatment histories react.
HEMATOLOGIC CANCER NEWS
Inqovi, an Oral Therapy for Myelodysplastic Syndromes, Gets FDA Approval
Cognitive Impairment Affects Survival Outcomes in Geriatric Patients Undergoing Allogeneic HCT
Trial Evaluating Pracinostat in AML Patients Unfit for Intensive Chemotherapy Discontinued
Negative Effects of Exercise Intolerance in Long-Term Cancer Survivors
Changes in Management of CLL Due to COVID-19 Noted in Italy
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers
